Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon beta induces T-helper 2 immune deviation in MS.

M E Kozovska1, J Hong, Y C Zang

  • 1Multiple Sclerosis Research and Neuroimmunology Laboratory, Department of Neurology and Baylor-Methodist International Multiple Sclerosis Center, Houston, TX, USA.

Neurology
|November 24, 1999
PubMed
Summary

Interferon beta-1a (IFN-beta1a) suppresses myelin basic protein (MBP)-reactive T cells in multiple sclerosis (MS) patients. This immune modulation favors anti-inflammatory cytokines, potentially explaining IFN-beta1a

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

[Research progress on intercellular junctions in corneal endothelial cells and their clinical significance].

[Zhonghua yan ke za zhi] Chinese journal of ophthalmology·2026
Same author

Predictors of traumatic brain injury amongst secondary school students in England: A retrospective cohort study using electronic health records.

Injury·2026

Area of Science:

  • Immunology
  • Neuroimmunology
  • Pharmacology

Background:

  • Multiple Sclerosis (MS) is an autoimmune disease characterized by immune system attacks on myelin.
  • Myelin basic protein (MBP)-reactive T cells are implicated in the pathogenesis of MS.
  • Interferon beta-1a (IFN-beta1a) is a therapeutic agent used in MS treatment, but its precise immunomodulatory mechanisms require further definition.

Purpose of the Study:

  • To elucidate the in vitro effects of IFN-beta1a on MBP-reactive T cells.
  • To investigate the regulatory impact of IFN-beta1a on cytokine networks in MS patients.
  • To explore the mechanism underlying IFN-beta1a's therapeutic benefit in MS.

Main Methods:

  • Proliferation assays (thymidine uptake) and ELISA were used to measure T-cell clone responses.

Related Experiment Videos

  • Microwell culture systems assessed the precursor frequency of MBP-reactive T cells.
  • Peripheral blood mononuclear cells (PBMCs) from MS patients were utilized for in vitro studies.

    • Main Results:

    • IFN-beta1a inhibited the proliferation of established MBP-reactive T-cell clones.
    • This inhibition correlated with increased anti-inflammatory cytokines (IL-4, IL-10) and decreased pro-inflammatory cytokines (TNF-alpha, IFN-gamma).
    • IFN-beta1a reduced the frequency of MBP-reactive T cells in PBMCs, accompanied by augmented IL-4 and IL-10 production.

    Conclusions:

    • IFN-beta1a suppresses MBP-reactive T cells and promotes a T-helper 2 immune deviation.
    • This immune modulation is a likely contributor to IFN-beta1a's therapeutic efficacy in MS.
    • The study identified heterogeneity in MBP-reactive T-cell responses to IFN-beta1a among MS individuals.